Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Abzena
Abzena
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Identifying and preventing contaminant leakage from your cleanroom
A common solution to machinery contamination in a cleanroom is to build a cleanroom within a cleanroom using partitions or curtains, to isolate the machine. Chris Lindlar from...
Integrity testing of HEPA filters: A practical approach
Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
Legionella testing: Modern alternatives to the ‘gold standard’ test
The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have...
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Design & Build
Abzena selects IPS for design and build of turnkey cGMP facility
Biopharma expert Abzena has chosen IPS to perform full design, construction management, and CQV services for its new monoclonal antibody (mAb) facility
Design & Build
Abzena takes modular approach to biologics suites
This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas
Finance
Abzena invests $60m into cGMP manufacturing capacity
The investment was reportedly driven by both existing customer requirements and by wider market demand
Richard Milbank joins Abzena
Design & Build
Abzena invests in new GMP biologics drug manufacturing plant
CEO announces US$20m investment into the expansion of biologics drug substance and ADC capabilities at new San Diego site
Pharmaceutical
Abzena and Telix sign manufacturing and bioconjugation agreement
The agreement between the developer and manufacturer of biopharmaceuticals and the radio-pharmaceuticals specialist is worth US$5.9 million
Pharmaceutical
Abzena chooses Sartorius
Sartorius Stedim Biotech has been named the preferred equipment supplier to Abzena CDMO facilities in the US
Subscribe now